An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin
Jonas Schädlich, Christoph Selg, Cathleen Haase-Kohn, Martin Ullrich, Robert Wodtke, Klaus Kopka, Evamarie Hey-Hawkins, Jens Pietzsch, Markus Laube · 2026
Read An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin by Jonas Schädlich, Christoph Selg, Cathleen Haase-Kohn, Martin Ullrich, Robert Wodtke, Klaus Kopka, Evamarie Hey-Hawkins, Jens Pietzsch, Markus Laube (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13257756.txt.
Description
Jonas Schädlich and co-authors try to build a radioactive tracer for imaging an inflammation enzyme in tumors in a 2026 study. A boron-cage version of indomethacin blocks COX-2 selectively, and swapping in iodine-123 aimed to make it visible on SPECT scans. Two iodine placements were synthesized and compared with the parent compound.
Both labeled versions blocked the enzyme less potently and less selectively than the parent. The better isomer was made radioactively, though isolated yield stayed low. The tracer held up in buffer but broke down at its ester link in plasma and liver extracts. Cell uptake was only partly enzyme-driven, and mouse scans showed clearance without tumor accumulation. Medicinal chemists get an honest negative: the labeling route works chemically, yet biology defeats this tracer design.
Catalog record
| CREATOR | Jonas Schädlich, Christoph Selg, Cathleen Haase-Kohn, Martin Ullrich, Robert Wodtke, Klaus Kopka, Evamarie Hey-Hawkins, Jens Pietzsch, Markus Laube |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |